Here are five insights:
1. Researchers analyzed 953 patients with stage III colon cancer during and 6 months after chemotherapy. Patients reported their intake of caffeinated coffee, decaffeinated coffee and non-herbal tea, as well as 128 other items.
2. Patients consuming four cups or more of coffee experienced an adjusted hazard ratio for colon cancer recurrence or mortality of 0.58, as compared with those who never drink coffee.
3. Patients consuming four cups or more of caffeinated coffee experienced significantly reduced cancer recurrence or mortality risk compared with abstainers.
4. Additionally, increasing caffeine intake also conferred a significant reduction in cancer recurrence or mortality.
5. Non-herbal tea and decaffeinated coffee did not impact patient outcome.
More articles on GI/endoscopy:
Exact Sciences’ price target hits $29
4 GI physicians in the news – Aug. 21, 2015
AGA proposes alternative to MOC recertification
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
